← Evidence map

ArticleCancer gene therapy2008

Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.

O Rautsi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

this papercites it

Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy. | OpenQuestion